Componenta (CTH1V) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
30 Oct, 2025Executive summary
Net sales for January–September 2025 reached €84.5 million, up 20.3% year-over-year, with EBITDA more than doubling to €6.9 million from €3.1 million.
Operating profit improved to €2.9 million from a loss of €0.9 million.
Order book at period end was €18.2 million, up from €13.9 million, supported by new business and market recovery.
Strong performance in energy and defense sectors offset weak demand in agricultural machinery.
Focus areas for 2025 include growth, profitability, resource planning, and strategic investments.
Financial highlights
Q3 2025 net sales were €24.8 million, up from €20.3 million year-over-year; Q3 EBITDA was €1.9 million, up from €1.2 million.
EBITDA and adjusted EBITDA both at €6.9 million, more than doubling from the prior year.
Operating profit turned positive at €2.9 million, compared to a loss of €0.9 million.
Cash flow from operating activities was negative at €-0.4 million, down from €1.0 million.
Basic EPS improved to €0.15 from €-0.27; diluted EPS to €0.14 from €-0.27.
Outlook and guidance
Guidance for 2025 remains unchanged: net sales and adjusted EBITDA expected to improve over 2024.
Financial targets for 2025–2027 include organic net sales exceeding €150 million and EBIT margin above 5% by 2027.
Market recovery signs are emerging, but agricultural machinery recovery is expected in 2026.
Order book development expected to remain positive, supported by investment backlog and new sales.
Plans to distribute one-third of annual net profit as dividends starting from 2025.
Latest events from Componenta
- Net sales and profitability surged, with strong cash and order book growth supporting a positive outlook.CTH1V
Q4 20256 Mar 2026 - Sales and profit surged, led by energy and defence, with strong cash flow and positive outlook.CTH1V
Q2 202523 Jul 2025 - Net sales and EBITDA fell, but Q3 improved and acquisitions support future growth.CTH1V
Q3 202413 Jun 2025 - Sales and profit fell, but new contracts and acquisitions signal recovery in H2 2024.CTH1V
Q2 202413 Jun 2025 - Sales and profitability surged, with strong liquidity and a positive outlook for 2025.CTH1V
Q1 20255 Jun 2025 - EBITDA and cash flow surged despite lower net sales, with a strong order book and positive outlook.CTH1V
Q4 20245 Jun 2025